INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines - BSX

Core Viewpoint - A class action lawsuit has been filed against Boston Scientific Corporation due to allegations of securities fraud and unlawful business practices following disappointing financial results and guidance [1] Financial Performance - On February 4, 2026, Boston Scientific reported its fourth quarter 2025 financial results, revealing lower-than-expected sales in its electrophysiology division [1] - The company issued guidance for fiscal year 2026 that significantly missed analyst expectations, attributing the results to slower market growth and increased competition [1] Stock Market Reaction - Following the announcement of the financial results and guidance, Boston Scientific's stock price dropped by $16.12 per share, or 17.6%, closing at $75.50 per share on February 4, 2026 [1]